Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology.

Scientific reports - 10 Feb 2026

Che Jingmin, Kwon Woo Sun, Kim Jaeyoung, Jadamba Erkhembayar, Han Hyo Jun, Kim Yuhnam, Lee Choong-Kun, Park Chan Hee, Moon Ye Jin, Mun Han Byeol, Chung Hyun Cheol, Rha Sun Young

Abstract excerpt

We developed a CancerMaster-targeted next generation sequencing (NGS) panel covering 524 key genes specifically designed for the multidimensional molecular profiling of solid tumors. We aimed to establish CancerMaster as an asynchronous and parallel one-stop automated analysis pipeline with a reporting system to overcome the delay in existing NGS approaches. This panel can detect common genomic alteration types,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Microsatellite Instability

Share to Mutation

Share to Neoplasms

Share to Precision Medicine

Share to Reproducibility of Results

Source

Open in PubMed Open full text

Identifiers

PMID: 41667751
DOI: 10.1038/s41598-026-37991-0
PMCID: PMC12957461

Genes

ERBB2
KRAS
PIK3CA
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology.PMID 41667751Read ↗

Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapySemantic proximity Read ↗

Next-Generation Sequencing in Oncology—A Guiding Compass for Targeted Therapy and Emerging ApplicationsSemantic proximity Read ↗

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical OncologySemantic proximity Read ↗

Analytical validation and clinical utilization of K-4CARE<sup>TM</sup>: a comprehensive genomic profiling assay with personalized MRD detectionSemantic proximity Read ↗

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologiesSemantic proximity Read ↗

A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors.Semantic proximity Read ↗

A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumoursSemantic proximity Read ↗

Development and validation of an ultra-high sensitive next-generation sequencing assay for molecular diagnosis of clinical oncology.Semantic proximity Read ↗

Validation of a next-generation sequencing assay for clinical molecular oncology.Semantic proximity Read ↗

Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer MedicineSemantic proximity Read ↗

Comprehensive genomic profiling for oncological advancements by precision medicine.Semantic proximity Read ↗

Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.